DIA 48th Annual Meeting
Click here to go to the previous page
Recent Advancement of HTA and Its Impact on Health Care Reform and Product Life Cycle Management in the Asian Pacific Region
Track
:
Track 13: Health Economics and Outcomes (HEO)/Comparative Effectiveness Research (CER)/Health Technology Assessment (HTA)
Program Code:
212
Date:
Tuesday, June 26, 2012
Time:
8:00 AM to 9:30 AM
EST
CHAIR
:
Chih-Hwa Wallace Lin, Center for Drug Evaluation, Taiwan
PRESENTER
(S):
Lawrence Liberti, Centre For Innovation In Regulatory Science (CIRS), United States
Leona Markson, Merck & Co., Inc., United States
Abdulkadir Keskinaslan, Novartis Pharma AG, Switzerland
Description
Systems for health technology assessments (HTAs) have been established in Taiwan and Korea. China is considering establishing a system similar to NICE. The session will discuss and compare HTA practices in the Pacific region, including Canada and the US.
Learning Objectives:
Discuss the advancement of HTA in the Asian Pacific region
Compare the various developments of HTA among Asian countries such as China, Japan, Korea, and Taiwan, as well as with Canada and the US
Discuss the impact on health insurance, health care reform and product life cycle management.
Learning Objectives:
Discuss the advancement of HTA in the Asian Pacific region
Compare the various developments of HTA among Asian countries such as China, Japan, Korea, and Taiwan, as well as with Canada and the US
Discuss the impact on health insurance, health care reform and product life cycle management.
This session is a part of:
Handout Online
